Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
111.12
+2.53 (2.33%)
At close: Oct 2, 2026, 4:00 PM EDT
111.92
+0.80 (0.72%)
After-hours: Oct 2, 2026, 7:58 PM EDT

Insmed Stock Forecast

Stock Price Forecast

According to 24 analysts polled by S&P Global, Insmed stock has a consensus rating of "Strong Buy" and an average price target of $197.74. The average 1-year stock price forecast is 77.95% higher than the current stock price, while the lowest is $169 (+52.09%) and the highest is $243 (+118.68%).

Price Target: $197.74 (+77.95%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$169$197.74$195$243
Change+52.09%+77.95%+75.49%+118.68%

Analyst Ratings

The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy171717181818
Buy455555
Hold000000
Sell000000
Strong Sell000000
Total212222232323

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Barclays
Barclays
Buy
Maintains
$237 → $207
BuyMaintains$237 → $207+86.29%Sep 30, 2026
J.P. Morgan
J.P. Morgan
Buy
Reiterates
$175
BuyReiterates$175+57.49%Sep 28, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$218
BuyMaintains$218+96.18%Sep 25, 2026
Goldman Sachs
Goldman Sachs
Buy
Initiates
$188
BuyInitiates$188+69.19%Sep 24, 2026
Mizuho Securities
Mizuho Securities
Buy
Maintains
$195
BuyMaintains$195+75.49%Sep 23, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.81B
from 606.42M
Increased by 198.15%
Revenue Next Year
2.88B
from 1.81B
Increased by 59.04%
EPS This Year
-1.54
from -6.42
EPS Next Year
0.77
from -1.54
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
188.46M245.36M305.21M363.71M606.42M1.81B
Revenue Growth
14.63%30.19%24.39%19.17%66.73%198.15%
Gross Profit
144.31M190.23M239.64M277.97M483.49M1.50B
Gross Margin
76.57%77.53%78.52%76.43%79.73%83.19%
Operating Income
-367.16M-478.12M-680.93M-786.57M-994.78M-311.68M
Net Income
-434.65M-481.53M-749.57M-913.77M-1.28B-349.78M
EPS
-----6.42-1.54
Free Cash Flow
-----967.58M-362.88M
No. Analysts
-----22
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.9B
Avg1.8B
Low1.7B

Revenue Growth

Revenue Growth202620272028
High
211.1%
Avg
198.2%
Low
173.9%

EPS Forecast

EPS202620272028
High-0.43
Avg-1.54
Low-2.65

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-